Amount Raised
$155,000
Round Type
Convertible Note
New YorkBiotechnologyHealth CareTherapeuticsresearchInvestors
Description
On October 31, 2025, Brainstorm Cell Therapeutics Inc entered into a securities purchase agreement with Vanquish Funding Group Inc. The agreement resulted in the issuance of a promissory note worth $182,400, from which the company received $155,000 after fees. The note is convertible into company shares under specific conditions. This funding will support the company's ongoing development of therapies for neurodegenerative diseases.
Quick answer
Brainstorm Cell Therapeutics raised $155,000 in a Convertible Note round, dated November 6, 2025. Investors: Vanquish Funding Group Inc. Brainstorm Cell Therapeutics is based in New York, New York, United States.
- How much did Brainstorm Cell Therapeutics raise?
- Brainstorm Cell Therapeutics raised $155,000 in a Convertible Note round on November 6, 2025.
- Who invested in Brainstorm Cell Therapeutics?
- Vanquish Funding Group Inc. is named as investors in this round.
- What does Brainstorm Cell Therapeutics do?
- BrainStorm Cell Therapeutics Inc. (OTCQB: BCLI) is a leading developer of autologous adult stem cell therapies for debilitating neurodegenerative diseases.
- Where is Brainstorm Cell Therapeutics based and how big is it?
- Brainstorm Cell Therapeutics is based in New York, New York, United States. Fundz records about 27 employees.
- Who are the decision-makers at Brainstorm Cell Therapeutics?
- Fundz holds 1 contact at Brainstorm Cell Therapeutics, including the Chief Executive Officer. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and research around the same time
Companies in the same sectors as Brainstorm Cell Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- AAVantgarde Bio raised $141M (Series B) on November 3, 2025.
- Faeth Therapeutics raised $25M (Funding Round) on October 20, 2025.
- Aarvik Therapeutics raised an undisclosed amount (Seed) on September 29, 2025.
- Corner Therapeutics raised $17M on September 26, 2025.
- Rezubio Pharmaceuticals raised $20M (Series A) on December 19, 2025.
- FoRx Therapeutics raised $50M (Series A) on December 18, 2025.
Who to call at Brainstorm Cell Therapeutics, and when
A new round usually means Brainstorm Cell Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Brainstorm Cell Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Brainstorm Cell Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Brainstorm Cell Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Brainstorm Cell Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Brainstorm Cell Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.